Tech Company Financing Transactions
Variantyx Funding Round
Variantyx, operating out of Framingham, scored $6 million from Robert Bosch Venture Capital.
Transaction Overview
Company Name
Announced On
11/15/2021
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Variantyx will use the funds to continue to develop its offerings to provide personalized oncology treatment based on unique genetic patterns.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1671 Worcester Rd. 300
Framingham, MA 01701
USA
Framingham, MA 01701
USA
Phone
Website
Email Address
Overview
Variantyx is a CLIA/CAP laboratory providing Genomic Unity, a whole genome sequencing (WGS)-based testing program for diagnosis of rare inherited disorders. Its single method approach to comprehensive genetic testing identifies multiple variant types within a single patient sample to provide a unified clinical report.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Haim Neerman
Chief Operating Officer
Yaron Rachmany
Chief Scientific Officer
Noam Shomron
Vice President
Daryl Spinner
VP - Customer Service
Tomer Jackman
VP - Marketing
Jennifer Hogan
VP - Sales
Chris Zerwas
Browse more venture capital transactions:
Prev: 11/15/2021: Cacheflow venture capital transaction
Next: 11/15/2021: Hive Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs